Featured Research

from universities, journals, and other organizations

Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice

Date:
January 24, 2001
Source:
University Of Pennsylvania Medical Center
Summary:
In a study of muscular dystrophy, scientists at the University of Pennsylvania School of Medicine have found that a common delivery system used in treating the disease through gene therapy may trigger an immune response in mice unless it is used in combination with a muscle-specific promoter that localizes the expression of genetic material.

In a study of muscular dystrophy, scientists at the University of Pennsylvania School of Medicine have found that a common delivery system used in treating the disease through gene therapy may trigger an immune response in mice unless it is used in combination with a muscle-specific promoter that localizes the expression of genetic material.

Related Articles


The study findings are published in the new issue of the journal Human Gene Therapy.

“Even when you use low-levels of a promoter that is not restricted to the afflicted area, you run the risk that you will immunize the patient against the very protein you are trying to get made,” said H. Lee Sweeney, PhD, chairman of the Department of Physiology at Penn and lead author of the study. “This is relevant because some of the clinical trials that have been started are not using restricted promoters. The journal wanted to get this message out there.”

In their published findings, the Penn researchers state that it is “crucial” to establish which method should be used before expanding clinical trials.

The scientists used two groups of mice that had been engineered to lack a protein called gamma sarcloc-glycan (gsg) in their muscles, which is the same protein that is missing in muscluar dystrophy (MD).

The researchers administered the protein to both groups of mice by enclosing the gsg in the recombinant adeno-associated virus (rAAV) – a commonly used vector that has been described in previous scientific research as non-immunogenic.

In one group of mice, the rAAV included a cytomegalovirus (CMV) promoter -- which will express the DNA material it carries in any tissue. The results Sweeney found: “Although we didn’t see the immune response in the CMV promoter in a large percentage of the mice – we did see it.”

In the second group of mice, when the rAAV that contained the gsg material was delivered under the control of the muscle creatine kinase promoter – which is muscle-specific -- there was no immune response.

“What we think happens is that if the virus gets into tissues that are very good at presenting foreign proteins to the immune system, then an immune response is generated to any proteins the virus may express,” Sweeney said. “Skeletal muscle (which is affected by MD) is very bad at presenting – we’ve never seen an immune response, as long as the expressed protein is restricted to the skeletal muscle.”

“The issue is: If you put DNA material into a virus that will fix the disease –will it also trigger an immune response?” Sweeney said.

“The answer appears to be – possibly. But as long as you keep the protein in the skeletal muscle and nowhere else, you don’t get an immune response.”

The study was funded by the National Institutes of Health, the Muscular Dystrophy Association and the Association Francaise contre les Myopathies.

Sweeney’s collaborators in the research were: Laurence Cordier, PhD, of Penn’s Department of Physiology; Andrew A. Hack, PhD, and Elizabeth M. McNally, PhD, both of the University of Chicago, and Guang-Ping Gao, PhD; Narendra Chirmule, PhD, and James M. Wilson, MD, PhD, of Penn’s Institute for Human Gene Therapy.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice." ScienceDaily. ScienceDaily, 24 January 2001. <www.sciencedaily.com/releases/2001/01/010123075357.htm>.
University Of Pennsylvania Medical Center. (2001, January 24). Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2001/01/010123075357.htm
University Of Pennsylvania Medical Center. "Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice." ScienceDaily. www.sciencedaily.com/releases/2001/01/010123075357.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins